SEC23A Regulated by Splicing Factor EIF3A may be Involved in the Development of Cervical Squamous Cell Cancer via Adherens Junction Pathway

Background: Cervical squamous cell cancer is a common malignancy in women globally. Increasing studies have indicated that there was an indivisible association between alternative splicing and cancer. However, comprehensive analysis of alternative splicing is scarce in cervical squamous cell cancer. Methods: Alternative mRNA splicing events data and clinical information of 216 cervical squamous cell cancer patients were downloaded from TCGA SpliceSeq database and TCGA website. We used identied survival-associated splicing events to construct prognostic signatures. Kaplan-Meier survival analysis and receiver operating characteristic curve were performed to evaluate the clinical value of prognostic signatures. A nomogram was carried out to quantitatively predict individuals’ survival probability. Regulatory network between splicing factors and survival-associated splicing events was analyzed. Additionally, we performed Pearson’s correlation analysis between survival-associated splicing events and pathways to explore potential downstream pathways. In order to verify the relationships between EIF3A and cell proliferation and migration, CCK8 and wound healing assays were conducted. Results: After sorting out survival-associated splicing events, multivariable regression analysis was used to acquire 70 survival-associated splicing events that could be independent prognostic factors for overall survival in cervical squamous cell cancer. A nomogram was constructed with a concordance index of 0.82. EIF3A positively regulated SEC23A-27346-AP with highest correlation coecient (P(cid:0)0.001, R=0.69). The most signicant KEGG pathways was adherens junction pathway (P=0.02, R=0.65). Cell proliferation and wound healing assays showed that EIF3A knockdown decreases cell proliferation and cell migration. Conclusion: Prognostic signatures of survival-associated splicing events were independent prognostic factors for overall survival among cervical squamous cell cancer patients. A nomogram could quantitatively predict individuals’ survival probability by integrating multiple risk factors. Moreover, SEC23A positively regulated by EIF3A may contribute to cervical squamous cell cancer via adherens junction pathway. This study may offer new direction for subsequent experimental research in cervical squamous cell cancer. ndings highlight the clinical signicance of AS-associated prognostic signatures in CESC. After integrating age, stage T, N, M and AS-associated prognostic signatures, we carried out a comprehensive analysis, that is nomogram, to quantitatively predict individuals’ survival probability. Compared with histopathological type or TNM stage, it had a more excellent performance in predicting survival time in CESC. These ndings suggest that AS-associated prognostic signatures may eventually act as ecient prognostic biomarkers to assess survival time in CESC. This is the rst and the most comprehensive analysis to construct a prognostic prediction model, which incorporate age, TNM stage and AS-associated prognostic signatures, in cervical squamous cell cancer. Survival-associated splicing events; SF: Splicing factors.


Introduction
Cervical squamous cell cancer (CESC) is the fourth most frequently detected malignancy and the fourth leading cause of cancer-associated death in women globally [1]. On the basis of the recent global cancer statistics, there were 570,000 newly diagnosed CESC cases and 311,000 deaths in 2018 worldwide [2].
The incidence and mortality of CESC in developing countries still drastically continue to rise, and CESC tends to occur in younger women [3]. Clinically, surgical resection, chemotherapy and radiotherapy, alone or combined, sometimes may be effective when treating early-stage, focal, sensitive CESC [4]. However, for a considerable proportion of CESC patients with unsatisfying treatment effect, we starve for a novel therapeutic strategy. In addition, clinical prediction for survival time depends heavily on histopathologic type, TNM stage and a fraction of tumor markers, while aforementioned indicators fail to predict survival time individually [5]. Along with the development of scienti c research, we discovered a growing number of biomarker or molecular mechanisms underlying tumorigenesis and progression. These molecular markers gradually guide the nosological classi cation, precisely evaluate the prognostic outcome, and even become an effective therapeutic target [6][7][8].
Alternative mRNA splicing (AS) is a ubiquitous biological process that can remarkably increase protein species diversity under the circumstance of a relatively nite number of genes [9]. The exact mechanism is that AS enables precursor mRNA to generate different types of mature mRNA by multiple combinations of introns and exons. There are seven types of alternative splicing pattern, that is, mutually exclusive exons (ME), retained intron (RI), alternate donor site (AD), alternate acceptor site (AA), alternate promotor (AP), alternate terminator (AT) and exon skip (ES) [10]. Under the physiological condition, AS plays a vitally important regulating effect in the process of development, tissue identity, differentiation, cell-to-cell communication, cell senescence and apoptosis [11][12][13]. AS is accurately regulated by extensive splicing factors which participate in the precise selection of splicing sites and subsequent splicing events [14].
Undoubtedly, aberrant splicing factors or abnormal expression of splicing factors directly leads to changes of splicing events expression, thus causing abnormal cell growth [15]. There is an increasing number of studies that AS also makes a critical difference in the development and progression of cancer [16]. The main mechanism may be the involvement of AS throughout the whole stage of cancer, including tumorigenesis, abnormal proliferation, progression, angiogenesis, metastasis, and immune escape [17][18][19]. A recent study hinted that there was an indivisible association between AS and cancer prognosis [20]. Therefore, it may be a credible prognostic biomarker and effective therapeutic target.
Previous studies demonstrated that AS event-associated signatures may act as prognostic biomarkers in some cancers, including stomach adenocarcinoma, colorectal cancer, prostate adenocarcinoma, sarcoma, bladder urothelial carcinoma and so on [21][22][23][24][25]. However, comprehensive pro les of alternative splicing events are still scarce in cervical squamous cell cancer.
In this study, we constructed an alternative splicing event-associated prognostic signature that could predict overall survival in cervical squamous cell carcinoma, and integrated multiple risk factors, including alternative splicing event-associated prognostic signature and clinical characteristics, to predict the individualized survival probability. Moreover, we investigated the potential interaction network between splicing events and splicing factors, and downstream regulatory network of alternative splicing events in CESC.

Data acquirement of alternative splicing events
The data of alternative splicing events for CESC were downloaded from the TCGA SpliceSeq database [26]. Clinical characteristics of 308 CESC patients were obtained by searching the TCGA website. 261 patients whose survival time was more than 90 days met the inclusion criteria. After we matched the patients with their TCGA SpliceSeq database items according to their sample ID, a total of 216 patients were included in our study.
Identi cation and construction of the prognostic signature Univariable cox regression analysis was carried out to identify survival-associated splicing events (SASEs). We used these candidate SASEs to construct prognostic signatures that could predict overall survival time. In order to avoid prognostic signatures over tting and build an optimal prognostic model, the least absolute shrinkage and selection operator (LASSO) regression analysis was applied to screen out splicing events whose absolute value of coe cients were greater than a predetermined value by using the R package "glmnet" [27]. After excluding SASEs with zero coe cients in the LASSO regression analysis, we calculated risk score of each patient for overall survival prediction by using the formula: PSI i , that is, percent-spliced-in, is a ratio that indicates the e ciency of splicing of sequences of interest into transcripts, and can be used to undertake an intuitive quantitative comparison of splicing events [28]. β i signi es the coe cients of SASEs in the LASSO regression model. CESC patients were divided into lowrisk and high-risk groups by using the median risk score as a cutoff value, respectively. Assessment of the clinical value of risk scores for prognostic signature Kaplan-Meier (K-M) survival analysis and receiver operating characteristic (ROC) curve were performed to assess the prognostic value of risk scores, with the area under ROC curve (AUC) indicating the predictive e cacy of prognostic signature construction. Multivariable cox proportional hazards regression analysis was conducted to validate whether risk scores were independent prognostic factors by using the "forestplot" package for R software.

Construction of nomogram
We constructed a nomogram to quantitatively gure out individuals' survival probability by incorporating multiple risk factors, including age, stage T, N, M and prognostic signatures of SASEs. According to risk contribution to survival probability, each risk factor was set as a speci c point. To assess the consistency between actual and predicted survival time, calibration curves were performed for 3-year and 5-year survival. Besides, concordance index, that is C-index, was calculated to evaluate whether the nomogram model had excellent performance for predicting survival time [29].

Construction of the potential correlation network
The data of splicing factors was extracted from the SpliceAid2 database, including 404 splicing factors [30]. Pearson correlation analysis was carried out to discovery the relationship between PSI value of SASEs and expression level of SFs. Correlation coe cient greater than 0.400 and P value less than 0.05 were considered to be statistically signi cant. Cytoscape 3.6.0 was used to build the potential correlation network [31].

Correlation of SASEs and KEGG pathways
We performed Gene Set Variation Analysis (GSVA) to screen out the differential Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in CESC [32]. Univariable cox regression analysis was utilized to identify the prognostic KEGG pathways related to overall survival. Pearson correlation analysis was carried out to compute the correlation coe cient between SASEs and prognostic KEGG pathways. Cell proliferation assay 24 hours after siRNA (scramble siRNA, or siRNA-EIF3A-1, or siRNA-EIF3A-2, or siRNA-EIF3A-3) transfection, cells were plated in 5 replicates in a 96-well plate (3000 cells/well) and cultured in DMEM supplemented with 10% FBS. Then, cells were incubated with 20 uL CCK8 reagent (Yeasen, China) for 2 hours at 37 °C as instructed by the manufacturer. Viable cells were counted after another 0, 24, 48, or 72 hours by reading the absorbance at 450 nm with a plate reader. The "0 hour" was the time when all seeded cells adhered to the plate.
Wound healing assay Cells were seeded in a 6-well plate and cultured in a complete medium until reaching 90% con uence.
Con uent monolayer cells were linearly scratched using 10 ul pipette tip, and then incubated for 24 hours in serum-free medium. The scratched region was photographed immediately or 24 hours after scratching using an inversion phase contrast microscope.

Statistical analysis
All statistical analyses were performed using R software version 3.4.1. Univariable and multivariable cox proportional hazards regression method were used to verify the association between alternative mRNA splicing events/prognostic signatures and overall survival. The least absolute shrinkage and selection operator (LASSO) regression analysis was applied to avoid prognostic signature over tting. The receiver operating characteristic (ROC) curve was applied to assess the sensitivity and speci city of prognostic prediction of risk score. Pearson correlation analysis was performed to calculate the correlation coe cients between SFs/KEGG pathways and SASEs. The scratch width from per experiment was calculated, and data were then obtained and expressed as mean ± standard deviation. A two-tailed P < 0.05 was considered to be statistically signi cant.

Results
Identi cation of survival-associated alternative mRNA splicing events in CESC The data of clinical characteristics and AS events of 216 CESC patients were analyzed. The clinical characteristics are listed in Table 1. In total, 41776 AS events in 9961 genes were detected, including 209 MEs in 202 genes, 2723 RIs in 1800 genes, 3017 ADs in 2106 genes, 3424 AAs in 2398 genes, 8066 APs in 3258 genes, 8395 ATs in 3664 genes and 15942 ESs in 6278 genes. The intersection between AS events related genes and alternative splicing event patterns in 216 CESC patients are displayed in Upset plot. AS shown in Fig. 1A, ES was the most common AS pattern and ME was the least common AS pattern in CESC, respectively. Besides, more than half of genes comprised ES events. In order to screen out survival associated alternative splicing events, univariable cox regression analysis was performed. Identi ed SASEs are illustrated in Upset plot (Fig. 1B). The most signi cant top 10 or 20 SASEs in each splicing pattern was selected and visualized in each bubble plot (Fig. 2).

Construction of prognostic signature for CESC
In order to construct an optimal prognostic signature, we integrated these most signi cant candidate SASEs into LASSO cox regression analysis, and calculated regression coe cients. After excluding AS events which could make prognostic signature over tting, we obtained 106 AS events signi cantly correlated with survival. Multivariable cox regression analysis was carried out to acquire 70 SASEs that could be an independent prognostic predictor for overall survival in CESC (Table 2). Then, we separately calculated risk score of each patient for overall survival prediction in each AS pattern as well as in all AS pattern. CESC patients were divided into low-risk and high-risk groups by using the median risk score as a cutoff value. The median risk score was set as 0.951 in AA pattern, 0.850 in AD pattern, 0.842 in AP pattern, 1.026 in AT pattern, 0.944 in ES pattern, 0.957 in ME pattern, 0.937 in RI pattern, and 0.809 in all pattern.

Assessment of the clinical value of prognostic signature
To validate the predictive e ciency of prognostic signature, K-M survival analysis and ROC curve were conducted. K-M survival analyses showed that the difference was statistically signi cant between lowrisk and high-risk groups for overall survival (P<0.01) (Fig. 3A-H). As shown in Fig. 3I-P, prognostic signatures of each AS pattern and all AS pattern had considerable predictive e cacy in differentiating better or worse outcomes for CESC patients. Prognostic signatures for AA (AUC = 0.951) and RI (AUC = 0.895) had optimal performance for predicting overall survival, and the area under ROC curve (AUC) for all AS pattern was 0.932. The correlation between risk score and overall survival was displayed in scatter plot and risk plot for 216 CESC samples. The red and green dots presented high-risk and low-risk group in risk plot. While in the scatterplot, these dots indicated survival status and overall survival of CESC patients, divided by median risk score of each AS pattern or all AS pattern. Expression level of SASEs in each AS pattern was visualized in the heatmap, with the red and green stripe indicating high and low PSI values, and the red and blue bars presenting low-risk and high-risk groups (Fig. 4A-H). Next, univariable and multivariable cox proportional hazards regression analyses were used to con rm whether prognostic signatures were independent prognostic factors in each AS pattern and all AS pattern. After integrating age, grade and cancer status, multivariate cox regression analyses con rmed that prognostic signatures for risk score were exactly independent prognostic factors for CESC patients (P<0.01). The aforementioned results were shown in forest map (Fig. 5A-H).

Nomogram
As we all known, age and TNM stage are independent prognostic factors in CESC. In order to obtain individuals' survival probability, we performed a comprehensive analysis of multiple risk factors. We constructed a nomogram to quantitatively predict the 3-year and 5-year survival by integrating age, stage T, N, M and prognostic signature of SASEs. According to risk contribution to survival probability, each risk factor was set as a speci c point. As shown in Fig. 6A, age less than 50 years old was assigned 68.75 points, stage T1-T2 was assigned 0 points, stage N1 was assigned 7.50 points, stage M0 was assigned 0 points, high-risk score was assigned 71.25 points and so on. Calibration curves showed that there was excellent consistency between actual and predicted survival time ( Fig. 6B-C). The concordance index (Cindex) was 0.82, indicating that the model had an excellent performance for predicting overall survival in CESC. For example, a 45-year old patient with high-risk score was in stage_T1-T2, stage_Nx, stage_M0 of cervical squamous cell cancer, she would get 147.5 points. Her 3-year survival rate was 65%, and 5-year survival rate was 50%.

SASEs and SFs correlation network in CESC
To explore the upstream regulators of SASEs, we carried out the Pearson correlation analysis to discovery the relationship between SASEs and SFs. The correlation network between 116 SASEs and 15 SFs were illustrated in Fig. 7. The purple arrows signi ed SFs, red and green circles represented high and low hazard ratio (HR) of SASEs by univariable cox regression analysis, as well as red and green lines indicated positive and negative regulation between SASEs and SFs. Our results showed that EIF3A had a positive regulation of SEC23A-27346-AP with highest correlation coe cient.

Correlation of SASEs and KEGG pathways
To explore the downstream pathways of SASEs, we screened out 185 differential KEGG pathways in CESC by using Gene Set Variation Analysis (GSVA). Univariable cox regression analysis was applied to identify 16 prognostic KEGG pathways related to overall survival. Then, the correlation coe cient of SASEs and prognostic KEGG pathways was calculated by using Pearson correlation analysis. The correlation between SASEs and prognostic KEGG pathways was illustrated in heatmap (Fig. 8). Knockdown of EIF3A decreases CESC cell proliferation and migration.
In order to verify the regulatory relationships between downregulated EIF3A level and CESC cell proliferation and migration, small interfering RNA (siRNA) transfection was performed. After con rming their successful establishment, these siRNAs were applied to a series of functional experiments. Knockdown of EIF3A signi cantly decrease cell proliferation of Hela viable cells (Fig. 9A). When dropping EIF3A levels, cell proliferation of SiHa viable cells reduced (Fig. 9B). However, Hela cell migration signi cantly decreased, after EIF3A expression levels was downregulated (Fig. 9C-D). Similarly, knockdown of EIF3A markedly decrease cell migration of SiHa cells (Fig. 9E-F).

Discussion
CESC is one of the frequently detected malignancies and pose a health threat to women all over the world [1][2][3]. Clinical stage, pathologic type, response to therapy and long-term prognosis can vary considerably among CESC patients. It is important for CESC patients to obtain survival time individually.
Research suggested that biomarkers, such as alternative mRNA splicing, might be an effective prognostic predictor[6]. AS is a vital biological process that can expand protein species diversity [9]. There is an increasing number of studies that AS plays a crucial role in the oncogenesis and development of cancer.
Previous studies reported that AS may accurately evaluate prognostic outcomes in some cancers, including glioblastoma multiforme, colorectal cancer, prostate adenocarcinoma, bladder urothelial carcinoma, gastric cancer and so on [23,24]. However, the relevant research of cervical squamous cell cancer is scarce.
In the present study, we constructed AS-associated prognostic signatures. AS-associated prognostic signatures were exactly independent prognostic factors in CESC. And prognostic signatures had high AUC values, proving prognostic signatures had reliable predictive e cacy. The ndings highlight the clinical signi cance of AS-associated prognostic signatures in CESC. After integrating age, stage T, N, M and ASassociated prognostic signatures, we carried out a comprehensive analysis, that is nomogram, to quantitatively predict individuals' survival probability. Compared with histopathological type or TNM stage, it had a more excellent performance in predicting survival time in CESC. These ndings suggest that AS-associated prognostic signatures may eventually act as e cient prognostic biomarkers to assess survival time in CESC. This is the rst and the most comprehensive analysis to construct a prognostic prediction model, which incorporate age, TNM stage and AS-associated prognostic signatures, in cervical squamous cell cancer.
Alternative splicing events are thought to be accurately regulated by hundreds of splicing factors, which speci cally combine with the splicing sites and participate in subsequent splicing events. There is no doubt that aberrant splicing factors or abnormal expression of splicing factors directly leads to changes of splicing events pattern and splicing events expression [14,15]. Some studies reported that there was correlation between splicing factors and poor prognosis in chronic lymphocytic leukemia, lung adenocarcinoma, pancreatic cancer, breast cancer and melanoma [33][34][35]. In our study, splicing factors were collected from the SpliceAid2 database, and correlation network between SASEs and SFs was explored. The most signi cant SASEs and SFs were SEC23A-27346-AP and EIF3A with the maximum correlation coe cient. EIF3A had a strongly positive regulation with SEC23A-27346-AP. Our ndings revealed that EIF3A might be the upstream regulator of SEC23A-27346-AP. The in-depth correlation analysis of regulation network between SESAs and SFs provides a new insight into the mechanism of AS involved in the unfavorable prognosis of cervical squamous cell cancer.
Alternative splicing events not only can be regulated by splicing factors, but also can respond to multiple signaling pathways. As we all know, weakening or lacking tight cell-cell adherens junction has been considered to be a fatal hallmark of cancer [36,37]. In normal physiological conditions, cell-cell adherens junction is the foundation of tissues architecture [38]. However, tumor cells tend to loss of adherens junctions, and display local dissemination and distant metastasis especially in advanced cancers.
Cadherins and catenins are the core proteins of cell-cell adherens junction. Low or loss of expression of cadherins and catenins inevitably lead to tumor progression and unfavorable prognosis [39]. In the current study, we selected prognostic KEGG pathways in CESC by Gene Set Variation Analysis (GSVA). The correlation analysis between SASEs and prognostic KEGG pathways was carried out. The most signi cant SASEs and prognostic KEGG pathways were SEC23A-27346-AP and adherens junction pathway with the maximum correlation coe cient. Therefore, we supposed that adherens junction pathway might be one of the downstream pathways of SEC23A-27346-AP in CESC.
SEC23A, as a core component of coat protein complex vesicles, can not only transport proteins but also cause human diseases. Aberrant SEC23A or abnormal expression of SEC23A was reported to be relevant to the development and progression of human cancer [40]. A previous study implicated that RNA binding motif 5 (RBM5) participate in regulating mRNA splicing of SEC23A [41]. However, our results indicated that SEC23A-27346-AP was associated with poor prognosis in CESC patients, and splicing factor EIF3A positively regulated SEC23A-27346-AP. Above all, SEC23A regulated by EIF3A may facilitate the development of cervical squamous cell cancer via adherens junction pathway.
EIF3A is the largest subunit of eukaryotic initiation factor 3 (EIF3), which plays a crucial role in all steps of translation initiation. Numbers of studies have shown that EIF3A exerts an important in uence on the regulation of cell cycle, cell growth and differentiation [42]. Recent studies have found that EIF3a is correlated with carcinogenesis, development and chemotherapy e cacy [43,44]. However, it is unknown whether EIF3A is a proto-oncogene in CESC. In the study, our results indicated that EIF3A knockdown decrease cell proliferation and cell migration of CESC. Therefore, EIF3A can promote proliferation and migration of CESC.
There are some limitations in this study. Firstly, the number of CESC patients in TCGA database was relatively small. Clinical information of 308 CESC patients was extracted from the TCGA website. After excluding the patients who didn't accord with the inclusive criteria, a total of 216 CESC patients were enrolled in our study. Secondly, we performed a nomogram to more precisely obtain individuals' survival probability by integrating multiple risk factors. However, we failed to take into consideration other risk factors, such as pathological grade, therapeutic strategies and so on. Moreover, the mechanism of alternative splicing events in the development of CESC was unclear. We carried out correlation analysis to explore upstream regulators and downstream pathways of alternative splicing events. In the meanwhile, we merely validated the relationship between EIF3A and CESC proliferation and migration. In the followup study, the molecular mechanisms of SEC23A and adherens junction pathway in the occurrence and development of cervical squamous cell cancer need further investigations to verify.

Conclusion
We constructed a splicing event-associated prognostic signature that could predict overall survival in cervical squamous cell carcinoma, and integrated multiple risk factors, including splicing eventassociated prognostic signature and clinical characteristics, to predict the individualized survival probability. Moreover, the potential interaction network between splicing events and splicing factors as         Knockdown of EIF3A decreases CESC cell proliferation and migration. Cell proliferation for the number of viable Hela and SiHa cells at 24h, 48h, and 72h using CCK-8 detection assays (A-B). Wound-healing assay for Hela cells after seeding. Representative photos are shown on the left (C-D). Wound-healing assay for SiHa cells after seeding (E-F). Column bars in (D) and (F) represent the wound healing rate from 3 independent experiments. Error bars represent ± SD. * P 0.05, ** P 0.01, *** P 0.001.